A comprehensive SARS-CoV-2 genomic analysis identifies potential targets for drug repurposing.
PLoS One. 2021 Mar 18;16(3):e0248553. doi: 10.1371/journal.pone.0248553. eCollection 2021.
PLoS One. 2021.
PMID: 33735271
Free PMC article.